A Meta-Analysis for Association of XRCC3 Rs861539, MTHFR Rs1801133, IL-6 Rs1800795, IL-12B Rs3212227, TNF-α Rs1800629, and TLR9 Rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2021 Nov 28

PMID 34837895

Citations 7

Authors

Seyedeh Fatemeh Parsaeian

Fatemeh Asadian

Mojgan Karimi-Zarchi

Sepideh Setayesh

Atiyeh Javaheri

Razieh Sadat Tabatabaie

Seyed Alireza Dastgheib

Hossein Golestanpour

Hossein Neamatzadeh

Affiliations

Soon will be listed here.

Abstract

Background: In spite of substantial declines in both incidence and mortality rates in the past 50 years, cervical cancer remains one of the leading causes of cancer associated mortality among women globally. We performed this meta-analysis to explore the role of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629 and TLR9 rs352140 polymorphism with susceptibility to cervical carcinoma.

Methods: The search databases include PubMed, SciELO, MedRxiv, Web of Science, Scopus, Cochrane Library, China National Knowledge Infrastructure, and China Biology Medicine disc up to 30 June 2021. The language is limited to English and Chinese. The comparison between the polymorphisms and cervical cancer was assessed using pooled odds ratio (OR) and 95% confidence interval (CI). The data are statistically analyzed by Comprehensive Meta-Analysis (CMA) 2.0 software.

Results: A total of 59 studies including seven studies with 1,112 cases and 1,233 controls on XRCC3 rs861539, 14 studies with 2,694 cases and 3349 controls MTHFR rs1801133, four studies with 1,121 cases and 1,109 controls on IL-12B rs3212227, seven studies with 1,452 cases and 2,186 controls on IL-6 rs1800795, 20 studies with 4,781 cases and 4909 controls on TNF-α rs1800629, and seven studies with 1743 cases and 2292 controls on TLR9 rs352140 were included. There was a significant association between XRCC3 RS861539, TNF-α rs1800629, and IL-6 rs1800795 polymorphisms and an increased risk of cervical carcinoma in overall population. However, the MTHFR rs1801133, IL-12B rs3212227 and TLR9 rs352140 polymorphisms were not associated.

Conclusion: The pooled analysis showed that XRCC3 RS861539, TNF-α rs1800629, and IL-6 rs1800795 were associated with cervical carcinoma susceptibility, but not MTHFR rs1801133, IL-12B rs3212227 and TLR9 rs352140 polymorphisms.

Citing Articles

Combination of inflammatory proteins in serum can be used to diagnose papillary thyroid carcinoma with lymph node metastasis.

Pan Y, Wang G, Chen D, Wu Z, Kei Y, Xu M Discov Oncol. 2025; 16(1):51.

PMID: 39812761 PMC: 11735717. DOI: 10.1007/s12672-025-01793-z.

Association of TNF-α genetic variants with neonatal bronchopulmonary dysplasia: consolidated results.

Shams S, Dastgheib S, Mousavi-Beni S, Hosein Lookzadeh M, Reza Mirjalili S, Golshan-Tafti M Front Pediatr. 2025; 12:1511355.

PMID: 39748810 PMC: 11693615. DOI: 10.3389/fped.2024.1511355.

Correlation of TNF-α polymorphisms with susceptibility to lung cancer: evidence from a meta-analysis based on 29 studies.

HaghighiKian S, Shirinzadeh-Dastgiri A, Ershadi R, Vakili-Ojarood M, Barahman M, Dastgheib S BMC Cancer. 2024; 24(1):1113.

PMID: 39243014 PMC: 11380323. DOI: 10.1186/s12885-024-12854-x.

A Comprehensive Integration of Data Regarding the Correlation of TNF-α rs1800629 Polymorphism with Susceptibility to Cervical Cancer.

Marzbanrad Z, Karimi-Zarchi M, Noei-Teymoordash S, Motamedinasab M, Azizi S, Noori-Ardebili S Asian Pac J Cancer Prev. 2024; 25(4):1155-1167.

PMID: 38679974 PMC: 11162705. DOI: 10.31557/APJCP.2024.25.4.1155.

Systematic evaluation of the association between a missense variant in XRCC3 gene splicing site and the pathogenesis of ovarian cancer.

Liang Q, Huang G, Zhong P, Deng D, Yang L, Yu X Biosci Rep. 2023; 43(6).

PMID: 37212185 PMC: 10272963. DOI: 10.1042/BSR20230462.

References

Sousa H, Oliveira S, Santos A, Catarino R, Moutinho J, Medeiros R . Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer. Tumour Biol. 2013; 35(3):2561-4. DOI: 10.1007/s13277-013-1337-3. View

Jarahzadeh M, Asadian F, Farbod M, Meibodi B, Abbasi H, Jafari M . Cancer and Coronavirus Disease (COVID-19): Comorbidity, Mechanical Ventilation, and Death Risk. J Gastrointest Cancer. 2020; 52(1):80-84. PMC: 7527425. DOI: 10.1007/s12029-020-00529-2. View

Pu X, Gu Z, Wang X . Polymorphisms of the interleukin 6 gene and additional gene-gene interaction contribute to cervical cancer susceptibility in Eastern Chinese women. Arch Gynecol Obstet. 2016; 294(6):1305-1310. DOI: 10.1007/s00404-016-4175-x. View

Deshpande A, Nolan J, White P, Valdez Y, Hunt W, Peyton C . TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis. 2005; 191(6):969-76. DOI: 10.1086/427826. View

Badano I, Stietz S, Schurr T, Picconi A, Fekete D, Quintero I . Analysis of TNFα promoter SNPs and the risk of cervical cancer in urban populations of Posadas (Misiones, Argentina). J Clin Virol. 2011; 53(1):54-9. DOI: 10.1016/j.jcv.2011.09.030. View

Zidi S, Stayoussef M, Alsaleh B, Gazouani E, Mezlini A, Ebrahim B . Relationships between Common and Novel Interleukin-6 Gene Polymorphisms and Risk of Cervical Cancer: a Case-Control Study. Pathol Oncol Res. 2016; 23(2):385-392. DOI: 10.1007/s12253-016-0127-9. View

Govan V, Constant D, Hoffman M, Williamson A . The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer. 2006; 6:24. PMC: 1397852. DOI: 10.1186/1471-2407-6-24. View

Lai Z, Ni-Zhang , Pan X, Song L . Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer. J Int Med Res. 2013; 41(4):1027-36. DOI: 10.1177/0300060513483398. View

Pal A, Kundu R . Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front Microbiol. 2020; 10:3116. PMC: 6985034. DOI: 10.3389/fmicb.2019.03116. View

10.

Prasad V, Wilkhoo H . Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers. Onkologie. 2011; 34(8-9):422-6. DOI: 10.1159/000331131. View

11.

Ghaemmaghami F, Karimi Zarchi M, Mousavi A . Surgical management of primary vulvar lymphangioma circumscriptum and postradiation: case series and review of literature. J Minim Invasive Gynecol. 2008; 15(2):205-8. DOI: 10.1016/j.jmig.2007.09.005. View

12.

Calhoun E, McGovern R, Janney C, Cerhan J, Iturria S, Smith D . Host genetic polymorphism analysis in cervical cancer. Clin Chem. 2002; 48(8):1218-24. View

13.

Yang S, Liu L, Xu D, Li X . The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies. Pathol Oncol Res. 2018; 26(1):307-315. DOI: 10.1007/s12253-018-0465-x. View

14.

Grimm C, Watrowski R, Baumuhlner K, Natter C, Tong D, Wolf A . Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia. Gynecol Oncol. 2011; 121(3):537-41. DOI: 10.1016/j.ygyno.2011.02.019. View

15.

Duvlis S, Dabeski D, Cvetkovski A, Mladenovska K, Plaseska-Karanfilska D . Association of TNF-a (rs361525 and rs1800629) with susceptibility to cervical intraepithelial lesion and cervical carcinoma in women from Republic of North Macedonia. Int J Immunogenet. 2020; 47(6):522-528. DOI: 10.1111/iji.12506. View

16.

Antikchi M, Neamatzadeh H, Ghelmani Y, Jafari-Nedooshan J, Dastgheib S, Kargar S . The Risk and Prevalence of COVID-19 Infection in Colorectal Cancer Patients: a Systematic Review and Meta-analysis. J Gastrointest Cancer. 2020; 52(1):73-79. PMC: 7524641. DOI: 10.1007/s12029-020-00528-3. View

17.

Jang W, Yang Y, Yea S, Lee Y, Chun J, Kim H . The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001; 166(1):41-6. DOI: 10.1016/s0304-3835(01)00438-4. View

18.

Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P . Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility. Mol Biol Rep. 2010; 38(7):4715-21. DOI: 10.1007/s11033-010-0607-z. View

19.

Kohaar I, Kumar J, Thakur N, Hussain S, Niyaz M, Das B . Homocysteine levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms in Indian population. Biomarkers. 2009; 15(1):61-8. DOI: 10.3109/13547500903295881. View

20.

Nath N, Mishra P, Panda A, Mishra R . Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India. Int Immunopharmacol. 2020; 88:106925. DOI: 10.1016/j.intimp.2020.106925. View